TORONTO, Nov. 16, 2016 /CNW/ - Valeant Canada, manufacturer of COLD-FX, is pleased to report Madame Justice Dillon of the British Columbia Supreme Court has dismissed the application for certification in the proposed B.C. class action proceeding relating to COLD-FX thereby dismissing a class action against Valeant with respect to the effectiveness of COLD-FX. Valeant is pleased to see this matter dismissed and looks forward to returning focus to our mission of improving people's lives with our healthcare products.
At Valeant, product safety is paramount. COLD-FX has been thoroughly evaluated, researched and clinically assessed and has been proven to help reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system.[i] For over a decade, more than $20 million has been invested in clinical research and development of COLD-FX. For the past eleven years, COLD-FX has been the #1 Pharmacist and Doctor Recommended Natural Cold Remedy brand in Canada.[ii]
About Valeant Canada and COLD-FX
COLD-FX is produced by Valeant Canada, a subsidiary of Valeant Pharmaceuticals International, Inc., a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about COLD-FX can be found at www.cold-fx.ca. More information about Valeant Canada can be found at www.valeantcanada.com.
[i] Health Canada "COLD-FX Monograph": https://health-products.canada.ca/lnhpd-bdpsnh/info.do?licence=80002849. Accessed on July 6, 2016
[ii] Canadian Healthcare Network. "2015 Counselling and Recommendations Survey." Retrieved from: http://www.canadianhealthcarenetwork.ca/otc2015/pharmacists-physicians. Accessed on February 8, 2016.
For further information: Rob McEwan, Argyle Public Relationships, 416-968-7311 ext. 242, [email protected]